Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer
Crossref DOI link: https://doi.org/10.1038/s41571-023-00851-1
Published Online: 2023-12-19
Published Print: 2024-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2023-12-19
Version of Record valid from 2023-12-19
Article History
First Online: 19 December 2023